The US Food and Drug Administration has approved a new drug application for a tablet version of Evrysdi (risdiplam) for people living with spinal muscular atrophy (SMA).

Ignored for most of its existence, the huge ice-bound island has been thrust into a geopolitical maelstrom. It’s trying to make the most of it. By Jeffrey Gettleman and Ivor Prickett Riyadh is ...